AAPG (Ascentage Pharma Group) Pangali Forward P/E
Ascentage Pharma Group is strengthening its global authority in oncology by developing breakthrough therapies. Current revenues are based on the supply of targeted drugs to Chinese clinics, while the expansion of international trials supports operational cash flow. Comparing the company's forward P/E NTM on GURU.Markets, we see a balance of these factors, where 0.00 shows the current value of the metric, reflecting the market's pricing of all R&D costs.
Ringkesan rincian data analitis Ascentage Pharma Corp (AAPG)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Ascentage Pharma Group|AAPG - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Ascentage Pharma Group|AAPG - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Ascentage Pharma Group International|AAPG - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Ascentage Pharma|Rasio cepet ascentage.com
- rincian asil keuangan lan kelipatan valuasi:
AAPG - Penghasilan resik perusahaan|Bathi sing dikarepake Ascentage Pharma Group|AAPG - Pangali rega marang bathi|Prakiraan rega marang bathi Ascentage|AAPG - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Ascentage Pharma Group International|AAPG - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Ascentage Pharma|AAPG - Bathi resik saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan ascentage.com|AAPG - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Ascentage Pharma Group
- indikator volume dodolan lan pendapatan:
Analisis komprehensif perusahaan:AAPG Ascentage Pharma
The forward P/E reflects the ratio of the current market share price to the projected earnings per share, allowing for an assessment of the premium paid for expected earnings. Analyzing the forward P/E value of Ascentage Pharma Group helps correlate investor speculative optimism with the actual commercialization rates of the company's targeted therapies, confirming the status of this innovator in global oncology.
Pesaing utama
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|CGON - Prakiraan rega marang bathi|URGN: Prakiraan rega marang bathi|BCAX - Pangali Forward P/E|Personalis (PSNL) - Rega marang bathi mangsa ngarep|Erasca Inc - Pangali mangsa ngarep rega marang bathi|DCTH (Delcath) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Y-mAbs Corp YMAB|Pangali Forward P/E AURA|Pangali Forward P/E candeltx.com (CADL)|Rega marang bathi mangsa ngarep Accuray ARAY|Kapitalisasi marang proyeksi bathi SELLAS Life Sciences Group, Inc. (SLS)|Actuate Therapeutics, Inc - Pangali Forward P/E|Citius Oncology Inc (CTOR) - Prakiraan rega marang bathi|HURA: Pangali Forward P/E|Rasio prakiraan rega marang bathi protaratx.com (TARA)|Rega marang bathi mangsa ngarep Fate Therapeutics|Rasio rega marang bathi mangsa ngarep WHWK (Aadi Bio)|Prakiraan rega marang bathi TCRX (TScan Therapeutics)|Rasio kapitalisasi marang bathi mangsa ngarep CSBR|Pangali Forward P/E XBIT (XBiotech)|Pangali Forward P/E CEL-SCI Corp. CVM|OS Therapies - Pangali Forward P/E|Pangali forward rega marang bathi radiopharmtheranostics.com (RADX)|ARTV: Pangali Forward P/E|Rasio prakiraan rega marang bathi Adlai Nortye (ANL)|Prakiraan rega marang bathi VERU|TPST: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Xilio Therapeutics, Inc. (XLO)|RENB: Rasio rega marang bathi sing dikarepake|Pangali Forward P/E MURA (Mural Oncology)|Pangali mangsa ngarep rega marang bathi KAPA|OnKure - Pangali Forward P/E|GDTC - Pangali Forward P/E|curis.com (CRIS) - Rega marang bathi mangsa ngarep|Apollomics - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Tharimmune Corp|Prakiraan rega marang bathi Advanced Biomed Corp (ADVB)|Pangali Forward P/E GNPX|Pangali Forward P/E calidibio.com (CLDI)|Sunshine Biopharma, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi XBIO|Salarius - Pangali Forward P/E|Pangali forward rega marang bathi Kitov Pharma (PPBT)|aoncology.com (AONC) - Rega marang bathi mangsa ngarep|beigene.com - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Checkpoint Therapeutics, Inc.|Rasio prakiraan rega marang bathi elevationoncology.com ELEV|Prakiraan rega marang bathi ICAD (iCAD, Inc.)|Pangali Forward P/E ikenaoncology.com (IKNA)|Rega marang bathi mangsa ngarep Notable Labs, Ltd. NTBL|VIRX (Viracta Therapeutics Inc.) - Rasio rega marang bathi sing dikarepake|MorphoSys - Pangali Forward P/E|NAYA - Pangali Forward P/E|AAPGV: Pangali Forward P/E
